Page last updated: 2024-08-26

glycidamide and Invasiveness, Neoplasm

glycidamide has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardanaz, E; Baglietto, L; Boeing, H; Boutron-Ruault, MC; Bueno-de-Mesquita, HB; Castaño, JM; Chamosa, S; Duell, EJ; Ferrari, P; Fortner, RT; Freisling, H; Gunter, MJ; Idahl, A; Khaw, KT; Klinaki, E; Lujan-Barroso, L; Lundin, E; Mattiello, A; Menéndez, V; Merritt, MA; Obón-Santacana, M; Onland-Moret, NC; Ose, J; Papatesta, EM; Peeters, PH; Riboli, E; Sacerdote, C; Saieva, C; Sánchez-Cantalejo, E; Severi, G; Tagliabue, G; Travis, RC; Trichopoulou, A; Tumino, R; Vesper, HW; Wareham, N; Weiderpass, E1

Other Studies

1 other study(ies) available for glycidamide and Invasiveness, Neoplasm

ArticleYear
Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016, Volume: 25, Issue:1

    Topics: Acrylamide; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Biomarkers; Case-Control Studies; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Epoxy Compounds; Female; Follow-Up Studies; Hemoglobins; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nutrition Assessment; Ovarian Neoplasms; Postmenopause; Prognosis; Prospective Studies; Risk Factors

2016